Capstone Therapeutics Corp. Contracts & Agreements

Amended and Restated Warrant to Purchase Common Stock, dated March 20, 2020, issued to BP Peptides, LLC (Filed With SEC on December 31, 2024)

Third Amendment to Securities Purchase Loan and Security Agreement dated March 27, 2020, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC (Filed With SEC on December 31, 2024)

Fourth Amendment to Securities Purchase Loan and Security Agreement dated March 15, 2021, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC (Filed With SEC on December 31, 2024)

Termination of Securities Purchase, Loan and Security Agreement, dated November 13, 2024, by and between Capstone Holding Corp. and BP Peptides, LLC (Filed With SEC on December 31, 2024)

Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March 27, 2020 and Effective as of November 26, 2021 (Filed With SEC on December 31, 2024)

Consent and First Amendment to the Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March 27, 2020 and Effective as of November 26, 2021 (Filed With SEC on December 31, 2024)

Second Amended and Restated Credit Agreement, dated March 8, 2023, by and between TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Stream... (Filed With SEC on December 31, 2024)

Consent, Waiver and Amendment to Second Amended and Restated Credit Agreement, dated October 18, 2024, by and between TotalStone, LLC, Northeast Masonry Distributors, LLC,... (Filed With SEC on December 31, 2024)

Non-negotiable Secured Subordinated Promissory Note by and between TotalStone, LLC and Northeast Masonry Distributors, LLC (Filed With SEC on December 31, 2024)

Non-negotiable Secured Subordinated Contingent Value Promissory Note by and between NEM Purchaser, LLC and Northeast Masonry Distributors, LLC (Filed With SEC on December 31, 2024)

Brookstone Partners IAC, Inc. Amended and Restated Management Fee Agreement Dated March 1, 2020 by and between TotalStone, LLC and Brookstone Partners IAC, Inc (Filed With SEC on December 31, 2024)

Management Fee Agreement, dated March 27, 2020, by and between TotalStone, LLC and Capstone Holding Corp (Filed With SEC on December 31, 2024)

Amendment of Amended and Restated Management Fee and Transaction Fee Agreement, dated November 15, 2024, by and between Capstone Holding Corp., TotalStone, LLC, and Brookstone... (Filed With SEC on December 31, 2024)

Limited Payment Guarantee dated March 31, 2021, between Capstone Therapeutics Corp. and Brookstone Acquisition Partners XXI Corporation (Filed With SEC on December 31, 2024)

LipimetiX Development, Inc. Contingent Value Rights Agreement, dated August 23, 2019, by and among Capstone Therapeutics Corp., the Shareholder Representative and Computershare... (Filed With SEC on December 31, 2024)

Second Amended and Restated Promissory Note, dated November 11, 2024, issued by Capstone Holding Corp. to BP Peptides, LLC (Filed With SEC on December 31, 2024)

Revolving Credit, Term Loan and Security Agreement by and among TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Berkshire Bank, dated... (Filed With SEC on December 31, 2024)

Amendments to Revolving Credit, Term Loan and Security Agreement Still in Effect As of December 30, 2024 (Filed With SEC on December 31, 2024)

Second Amended and Restated Revolving Credit Note Issued by TotalStone, LLC and Northeast Masonry Distributors, LLC to Berkshire Bank, dated November 14, 2019 (Filed With SEC on December 31, 2024)

Term Note Issued by TotalStone, LLC, Northeast Masonry Distributors, LLC, and TotalStone Properties, LLC to Berkshire Bank, dated November 22, 2021 (Filed With SEC on December 31, 2024)

Second Amended and Restated Promissory Note Issued by Capstone Holding Corp. to Brookstone Partners Acquisition XXI Corporation, dated November 11, 2024 (Filed With SEC on December 31, 2024)

Contingent Value Rights Agreement (Filed With SEC on August 26, 2019)

Third Amendment to the Securities Purchase, Loan and Securities Agreement Dated as of August 23, 2019 (Filed With SEC on August 26, 2019)

Second Amendment to Securities Purchase, Loan and Security Agreement dated March 15, 2019, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC (Filed With SEC on March 19, 2019)

License Agreement dated May 2, 2018, by and between LipimetiX Development, Inc. and ANJI Pharmaceuticals Inc (Filed With SEC on May 7, 2018)

First Amendment to Securities Purchase Loan and Security Agreement dated January 30, 2018, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC (Filed With SEC on February 1, 2018)

Warrant to Purchase Common Stock dated January 30, 2018 (Filed With SEC on February 1, 2018)

SERIES B-2 PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on August 14, 2017)

FIRST AMENDMENT TO THE AMENDED AND RESTATEDSTOCKHOLDERS AGREEMENT OF LIPIMETIX DEVELOPMENT, INC. (Filed With SEC on August 14, 2017)

JOINDER AND COUNTERPART SIGNATURE PAGE OF REGISTRATION RIGHTS AGREEMENT OF LIPIMETIX DEVELOPMENT, INC. (Filed With SEC on August 14, 2017)

CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIPIMETIX DEVELOPMENT, INC. (Filed With SEC on August 14, 2017)

FIRST AMENDMENT TO BYLAWS OF LIPIMETIX DEVELOPMENT, INC. (August 10, 2017) (Filed With SEC on August 14, 2017)

SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENT (Filed With SEC on July 17, 2017)

PROMISSORY NOTE (Filed With SEC on July 17, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 17, 2017)

3rd Letter Agreement (Filed With SEC on June 30, 2017)

2nd Letter Agreement (Filed With SEC on June 15, 2017)

Letter Agreement (Filed With SEC on May 4, 2017)

Tax Benefit Preservation Plan, dated as of April 18, 2017, by and between Capstone Therapeutics Corp. and Computershare Inc., as rights agent (Filed With SEC on April 19, 2017)

LIPIMETIX DEVELOPMENT, INC. SERIES B PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on August 26, 2016)

LIPIMETIX DEVELOPMENT, INC. WARRANT TO PURCHASE SERIES B-1 PREFERRED STOCK (Filed With SEC on August 26, 2016)

Exhibit 10.3 – Series B Preferred Stock and Warrant PurchaseAgreement - Exhibit C – Form of Amended and Restated Certificate of Incorporation of LipimetiX Development, Inc.... (Filed With SEC on August 26, 2016)

Exhibit 10.4 -Series B Preferred Stock and Warrant PurchaseAgreement - Exhibit F – Form of Registration Rights Agreement REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 26, 2016)

AMENDED AND RESTATED STOCKHOLDERS AGREEMENT among LIPIMETIX DEVELOPMENT, INC. and THE STOCKHOLDERS NAMED HEREIN Dated as of August 25, 2016 (Filed With SEC on August 26, 2016)

Management Agreement (Filed With SEC on July 29, 2016)

ACCOUNTING SERVICES Agreement (Filed With SEC on July 29, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 15, 2015)

EXHIBIT A CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 15, 2015)

********************* (Filed With SEC on September 16, 2015)

COMMON STOCK PURCHASE WARRANT CAPSTONE THERAPEUTICS CORP. (Filed With SEC on September 16, 2015)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 16, 2015)

STATE OF DELAWARE CERTIFICATE OF CONVERSION FROM A DELAWARE LIMITED LIABILITY COMPANY TO A DELAWARE CORPORATION PURSUANT TO SECTION 265 OF THE DELAWARE GENERAL CORPORATE LAW (Filed With SEC on June 26, 2015)

PLAN OF CONVERSION (Filed With SEC on June 26, 2015)

STOCKHOLDERS AGREEMENT among LIPIMETIX DEVELOPMENT, INC. and THE STOCKHOLDERS NAMED HEREIN Dated as of June 23, 2015 LIPIMETIX DEVELOPMENT, INC. STOCKHOLDERS AGREEMENT (Filed With SEC on June 26, 2015)

LETTER OF INCENTIVE STOCK OPTION GRANT CAPSTONE THERAPEUTICS CORP. 2015 EQUITY INCENTIVE PLAN (Filed With SEC on June 22, 2015)

LETTER OF NON-QUALIFIED OPTION GRANT CAPSTONE THERAPEUTICS CORP. 2015 EQUITY INCENTIVE PLAN (Filed With SEC on June 22, 2015)

SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on January 30, 2015)

TAX BENEFIT PRESERVATION PLAN Dated as of June 24, 2014 by and between CAPSTONE THERAPEUTICS CORP. and COMPUTERSHARE INC., as Rights Agent (Filed With SEC on June 24, 2014)

ACCOUNTING SERVICES AGREEMENT AMENDMENT #1 (Filed With SEC on November 12, 2013)

CAPSTONE THERAPEUTICS CORP. JOINT VENTURE BONUS PLAN (Filed With SEC on November 8, 2012)

CONTRIBUTION AGREEMENT (Filed With SEC on August 10, 2012)

AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF LIPIMETIX DEVELOPMENT, LLC (Filed With SEC on August 10, 2012)

EXHIBIT 10.3EXECUTION FIRST AMENDMENT AND CONSENT TO ASSIGNMENT OF EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 10, 2012)

MANAGEMENT AGREEMENT (Filed With SEC on August 10, 2012)

EXHIBIT 10.5EXECUTION ACCOUNTING SERVICES AGREEMENT (Filed With SEC on August 10, 2012)

ESCROW AGREEMENT (Filed With SEC on August 10, 2012)

Capstone Therapeutics Provides Operating Update And Announces 2011 Financial Results (Filed With SEC on March 21, 2012)

First Amendment to Lease dated April 28, 2010 by and between OrthoLogic Corp. and Phoenix Investors #20, L.L.C (Filed With SEC on August 9, 2010)

First Amendment to Rights Agreement, dated as of May 21, 2010, between Capstone Therapeutics Corp. and The Bank of New York (Filed With SEC on May 25, 2010)

Amendment No. 3, dated November 4, 2008, to the Management Services Agreement effective May 12, 2006 by and between AGP Management, LP, John M. Holliman, III, Executive Chairman,... (Filed With SEC on November 6, 2008)

Amendment No. 3, dated November 4, 2008, to the Employment Agreement effective May 12, 2006, between Randolph C. Steer, MD, Ph.D., President, and OrthoLogic Corp (Filed With SEC on November 6, 2008)

Amended and Restated Class D Warrant Agreement dated February 24, 2006, and amended and restated as of June 30, 2006, related to the Common Stock and Warrant Purchase Agreement by... (Filed With SEC on March 5, 2008)

Amendment #1 to Employment Agreement dated May 21, 2007, between Randolph C. Steer, MD, Ph.D., President, and OrthoLogic Corp (Filed With SEC on March 5, 2008)

Amendment #2 to Employment Agreement dated February 21, 2008, between Randolph C. Steer, MD, Ph.D., President, and OrthoLogic Corp (Filed With SEC on March 5, 2008)

*************************** (Filed With SEC on July 23, 2007)

RIGHTS AGREEMENT between ORTHOLOGIC CORP. and THE BANK OF NEW YORK Dated: As of June 19, 2007 Table of Contents (Filed With SEC on June 25, 2007)

Amended and Restated Class C Warrant Agreement related to the Common Stock and Warrant Purchase Agreement by and between OrthoLogic Corp. and PharmaBio Development, Inc (Filed With SEC on May 7, 2007)

Purchase Agreement dated March 6, 2007 by and between the Company and Presson Advisory, LLC (Filed With SEC on March 9, 2007)

Separation Agreement and Release dated November 17, 2006, by and between the Company and James T. Ryaby, Ph.D (Filed With SEC on November 24, 2006)

Consulting Agreement dated November 17, 2006, by and between the Company and James T. Ryaby, Ph.D (Filed With SEC on November 24, 2006)

Current assets (Filed With SEC on August 8, 2006)

CLASS A WARRANT AGREEMENT (Filed With SEC on July 6, 2006)

ORTHOLOGIC CORP. 2005 EQUITY INCENTIVE PLAN (Filed With SEC on May 18, 2006)

LETTER OF INCENTIVE OPTION GRANT ORTHOLOGIC CORP. 2005 EQUITY INCENTIVE PLAN (Filed With SEC on May 18, 2006)

LETTER OF NON-QUALIFIED OPTION GRANT ORTHOLOGIC CORP. 2005 EQUITY INCENTIVE PLAN (Filed With SEC on May 18, 2006)

LETTER OF RESTRICTED STOCK GRANT ORTHOLOGIC CORP. 2005 EQUITY INCENTIVE PLAN (Filed With SEC on May 18, 2006)

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers (Filed With SEC on April 11, 2006)

Option exercisable for (Filed With SEC on January 19, 2006)

EMPLOYMENT AGREEMENT (Salaried Employees) (Filed With SEC on January 11, 2006)

INTELLECTUAL PROPERTY, CONFIDENTIALITY AND NON-COMPETITION AGREEMENT (EMPLOYEES) (Filed With SEC on January 11, 2006)

INDEMNIFICATION AGREEMENT (Filed With SEC on January 11, 2006)

Exhibit No (Filed With SEC on December 28, 2005)

EMPLOYMENT AGREEMENT (Salaried Employees) (Filed With SEC on October 27, 2005)

INTELLECTUAL PROPERTY, CONFIDENTIALITY AND NON-COMPETITION AGREEMENT (EMPLOYEES) (Filed With SEC on October 27, 2005)

PART I Financial Information (Filed With SEC on August 9, 2005)

Exhibit No (Filed With SEC on June 16, 2005)

Current assets (Filed With SEC on May 10, 2005)

EMPLOYMENT AGREEMENT (Filed With SEC on March 4, 2005)

CONFIDENTIAL INFORMATION AND ASSIGNMENT OF INVENTIONS AGREEMENT (Filed With SEC on March 4, 2005)

LETTER OF STOCK OPTION GRANT ORTHOLOGIC CORP. 1997 STOCK OPTION PLAN (Filed With SEC on March 4, 2005)

LETTER OF STOCK OPTION GRANT ORTHOLOGIC CORP. (Filed With SEC on March 4, 2005)

LETTER OF RESTRICTED STOCK GRANT ORTHOLOGIC CORP. (Filed With SEC on March 4, 2005)

LETTER OF INCENTIVE OPTION GRANTORTHOLOGIC CORP. STOCK OPTION PLAN (Filed With SEC on January 4, 2005)

LETTER OF NON-QUALIFIED OPTION GRANT ORTHOLOGIC CORP. 1997 STOCK OPTION PLAN (Filed With SEC on January 4, 2005)

Current assets (Filed With SEC on November 9, 2004)

AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on August 6, 2004)

The expected increased value from having all Chrysalin patent license rights owned by a single entity rather than having multiple owners of rights for different indications (Filed With SEC on June 3, 2004)

Legal Proceedings (Filed With SEC on March 15, 2004)

Financial statements of the business acquired. None (Filed With SEC on December 11, 2003)

Financial Information (Filed With SEC on November 14, 2003)

Exhibit No (Filed With SEC on October 20, 2003)

Category

Industry

Companies

Contracts

Capstone Therapeutics Corp. Contracts & Agreements